The role of CXC chemokines in the regulation of angiogenesis in association with lung cancer

Trends in Cardiovascular Medicine

Volumn 8, Issue 2, 1998, Pages 51-58

  Moore, Bethany B ^a   Arenberg, Douglas A ^a   Strieter, Robert M ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; CHEMOKINE; EPIDERMAL GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 8; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

AMINO TERMINAL SEQUENCE; ANGIOGENESIS; CANCER GROWTH; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; METASTASIS POTENTIAL; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SIGNAL TRANSDUCTION; TREATMENT PLANNING; TUMOR VASCULARIZATION;

EID: 0031908531     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(97)00128-X     Document Type: Review

References (40)

1. Arenberg DA, Kunkel SL, Polverini PJet al. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J Clin Invest. 97:1996;2792-2802.
2. Arenberg DA, Kunkel SL, Polverini PJet al. Interferon-γ-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J Exp Med. 184:1996;981-992.
3. Baggiolini M, Dewald B, Walz A: 1992. Interleukin-8 and related chemotactic cytokines. In Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: Basic Principles and Clinical Correlates. New York, Raven Press, pp. 247-263.
4. Brem H, Gresser I, Grosfeld J, Folkman J The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis. J Pediatr Surg. 28:1993;1253-1257.
5. Engerman RL, Pfaffenenbach D, Davis MD Cell turnover of capillaries. Lab Invest. 17:1967;738-743.
6. Farber JM HuMIG: a new member of the chemokine family of cytokines. Biochem Biophys Res Commun. 192:1993;223-230.
7. Folkman J: 1993. Tumor angiogenesis. In Holland JF, Frei E III, Bast RC Jr, Kufe DW, Morton DL, Weischelbaum RR, eds. Cancer Medicine, 3rd ed. Philadelphia, Lea & Febiger, pp 153-170.
8. Harpole DH Jr., Richards WG, Herndon JE, Sugarbaker DJ Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer. Ann Thorac Surg. 61:1996;1470-1476.
9. Herlyn M, Clark WH, Rodeck Uet al. Biology of tumor progression in human melanocytes. Lab Invest. 56:1987;461-474.
10. Ingber DE Extracellular matrix and cell shape: potential control points for the inhibition of angiogenesis. J Cell Biochem. 47:1991;236-241.
11. Klagsburn M, D'Amore PA Regulators of angiogenesis. Annu Rev Physiol. 53:1991;217-239.
12. Koch AE, Polverini PJ, Kunkel SLet al. Interleukin-8 (IL-8) as a macrophage-derived mediator of angiogenesis. Science. 258:1992;1798-1801.
13. Langer R, Conn H, Vacanti J, Haudenschild CC, Folkman J Control of tumor growth in animals by infusion of an antiangiogenesis inhibitor. Proc Natl Acad Sci USA. 77:1980;4331-4335.
14. Lee A, Langer R Shark cartilage contains inhibitors of tumor angiogenesis. Science. 221:1983;1185-1187.
15. Leibovich SJ, Weisman DM Macrophages, wound repair and angiogenesis. Prog Clin Biol Res. 266:1988;131-145.
16. Loetscher M, Gerber B, Loetscher Pet al. Chemokine receptor specific for IP-10 and Mig: structure, function, and expression in activated T-lymphocytes. J Exp Med. 184:1996;963-969.
17. Luster AD, Unkeless JC, Ravetch JV Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature. 315:1985;672-676.
18. Luster AD, Greenberg SM, Leder P The IP-10 chemokine binds to a specific cell surface heparan sulfate shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med. 182:1995;219-232.
19. Lutty GA, Thompson DC, Gallup JY, Mello RJ, Fenselau A Vitreous: an inhibitor of retinal extract-induced neovascularization. Inv Opthalmol Vis Sci. 24:1983;52-56.
20. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA Relation of neovascularization to metastasis of non-small cell lung cancer. Lancet. 340:1992;145-146.
21. Madri JA, Pratt BM, Tucker AM Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix. J Cell Biol. 106:1988;1375-1384.
22. Maione TE, Gray GS, Petro Jet al. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science. 247:1990;77-79.
23. Maione TE, Gray GS, Hunt AJ, Sharpe RJ Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. Cancer Res. 51:1991;2077-2083.
24. Minna JD: 1991. Neoplasms of the lung. In Isselbacher KJ, ed. Principles of Internal Medicine, 12th ed. New York, McGraw-Hill, pp 1102-1110.
25. Nanney LB, Mueller SG, Bueno R, Peiper SC, Richmond A Distributions of melanoma growth stimulatory activity or growth-related gene and the interleukin-8 receptor type B in human wound repair. Am J Pathol. 147:1995;1248-1260.
26. Oppenheim JJ, Zachariae OC, Mukaida N, Matsushima K Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol. 9:1991;617-648.
27. Schnyder-Candrian S, Strieter RM, Kunkel SL, Walz AA Interferon-α and interferon-γ downregulate the production of interleukin-8 and ENA-78 in human monocytes. J Leuk Biol. 57:1995;929-935.
28. Sharpe RJ, Byers HR, Scott CF, Bauer SI, Maione TE Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4. J Natl Cancer Inst. 82:1990;848-853.
29. Shields PG, Harris CC: 1993. Genetic predisposition to cancer. In Roth JA, Cox JD, Hong WK, eds. Lung Cancer. Boston, MA. Blackwell Scientific Publishing, pp 3-19.
30. Shirozu M, Nakano T, Inazawa Jet al. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF-1) gene. Genomics. 28:1995;495-500.
31. Smith DR, Polverini PJ, Kunkel SLet al. IL-8 mediated angiogenesis in human bronchogenic carcinoma. J Exp Med. 179:1994;1409-1415.
32. Standiford TJ, Kunkel SL, Basha MAet al. Interleukin-8 gene expression by a pulmonary epithelial cell line: a model for cytokine networks in the lung. J Clin. Invest. 86:1990;1945-1953.
33. Strieter RM, Kunkel SL: 1997. Chemokines and the lung. In Crystal R, West J, Weibel E, PBP. Lung: Scientific Foundations, 2nd ed. New York, Raven Press, pp 155-186.
34. Strieter RM, Kunkel SL, Showell Het al. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-α, LPS, and IL-1β Science. 243:1989;1467-1469.
35. Strieter RM, Kunkel SL, Elner VMet al. Interleukin-8: a corneal factor that induces neovascularization. Am J Pathol. 141:1992;1279-1284.
36. Strieter RM, Polverini PJ, Kunkel SL, et al.: 1995. The functional role of the 'ELR' motif in CXC chemokine-mediated angiogenesis. J Biol Chem 270:27,348-27,357.
37. Walz A, Baggiolini M Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases. Exp Med. 171:1990;449-454.
38. Walz A, Kunkel SL, Strieter RM: 1996. CXC chemokines-an overview. In Koch AE, Strieter RM, eds. Chemokines in Disease, Austin, TX, RG Landes, pp 1-26.
39. Weidner N Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol. 147:1995;9-19.
40. Yuan A, Pan-Chyr Y, Chong-Jen Yet al. Tumor angiogenesis correlates with histologic type and metastasis in non-small cell lung cancer. Am J Resp Crit Care Med. 152:1995;2157-2162.